Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.

Xu Y, Liu J, Du X, Sun X, Zheng Y, Chen J, Li B, Liu W, Jiang H, Mao W.

Radiat Oncol. 2013 May 8;8:116. doi: 10.1186/1748-717X-8-116.

2.

Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.

Chen J, Wu S, Zheng X, Pan J, Zhu K, Chen Y, Li J, Liao L, Lin Y, Liao Z.

BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.

3.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
4.
5.

[Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].

Wang Y, Wang L, Yang Q, Li J, He M, Yao J, Qi Z, Li B, Qiao X.

Zhonghua Zhong Liu Za Zhi. 2016 Jan;38(1):48-54. doi: 10.3760/cma.j.issn.0253-3766.2016.01.010. Chinese.

PMID:
26796807
6.

Impact of postoperative radiation after esophagectomy for esophageal cancer.

Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M.

J Thorac Oncol. 2010 Feb;5(2):244-50. doi: 10.1097/JTO.0b013e3181c5e34f.

7.

Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma.

Murakami M, Kuroda Y, Nakajima T, Okamoto Y, Mizowaki T, Kusumi F, Hajiro K, Nishimura S, Matsusue S, Takeda H.

Dis Esophagus. 1999;12(4):270-5.

PMID:
10770361
8.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1484-93.

PMID:
15590179
9.

Prognostic factors of radiotherapy in patients with node-positive thoracic esophageal squamous cell carcinoma after radical surgery.

Lu JC, Tao H, Chen ZZ, Qian PD.

Dis Esophagus. 2009;22(6):490-5. doi: 10.1111/j.1442-2050.2008.00936.x.

PMID:
19191849
10.

Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.

Ren Y, Su C, Zhou Y, Zhao X, Yang CL, Liu YY.

World J Gastroenterol. 2014 Dec 21;20(47):17970-5. doi: 10.3748/wjg.v20.i47.17970.

11.

[Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].

Lin Y, Chen J, Li J, Liu J, Zhu K, Pan C, Chen M, Pan J.

Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):151-4. Chinese.

PMID:
24796467
12.

[Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].

Yang Q, Wang YX, He M, Li J, Qi Z, Zhu SC, Qiao XY.

Zhonghua Zhong Liu Za Zhi. 2016 Jul;38(7):530-7. doi: 10.3760/cma.j.issn.0253-3766.2016.07.010. Chinese.

PMID:
27531268
13.

Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.

Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):475-82. doi: 10.1016/j.ijrobp.2010.08.037.

PMID:
20934269
14.

Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?

Chen G, Wang Z, Liu XY, Liu FY.

Ann Thorac Surg. 2009 Jun;87(6):1697-702. doi: 10.1016/j.athoracsur.2009.03.060.

PMID:
19463580
15.

Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.

Chen G, Wang Z, Liu XY, Zhang MY, Liu FY.

Eur J Cardiothorac Surg. 2009 Jan;35(1):1-7. doi: 10.1016/j.ejcts.2008.09.002.

PMID:
18926712
16.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
17.

Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma.

Lu JC, Tao H, Zhang YQ, Zha WW, Qian PD, Li F, Xu KX.

Dis Esophagus. 2008;21(6):502-7. doi: 10.1111/j.1442-2050.2007.00797.x.

PMID:
18840135
18.

Primary mucoepidermoid carcinoma of the esophagus.

Chen S, Chen Y, Yang J, Yang W, Weng H, Li H, Liu D.

J Thorac Oncol. 2011 Aug;6(8):1426-31. doi: 10.1097/JTO.0b013e31821cfb96.

19.

The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.

Qin RQ, Wen YS, Wang WP, Xi KX, Yu XY, Zhang LJ.

Med Oncol. 2016 Apr;33(4):31. doi: 10.1007/s12032-016-0746-8.

PMID:
26922662
20.

Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.

Liu J, Hu Y, Xie X, Fu J.

Ann Thorac Surg. 2012 Feb;93(2):423-7. doi: 10.1016/j.athoracsur.2011.10.011.

PMID:
22178587
Items per page

Supplemental Content

Support Center